CopyMark Law Group
4.9/5
Drawing for ASKFIRST

USPTO serial 98201386

ASKFIRST

Reviewed by CopyMark Law Group

Reg. 8064544Status 700Registered
Filing date
Status date
Registration date
Dec 16, 2025
Examiner
CAYSIDO, REBECCA TOLENTINO
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ASKFIRST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristen Mollnow Walsh

Kristen Mollnow Walsh Nixon Peabody LLP211 High Point Drive, Suite 110Victor, NY 14564-1061United States

Goods and services

ClassDescriptionStatusFirst use
035Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to achieve advances in therapeutics, technology, regulatory requirements, and public policy in the field of healthcare, genetic disease, gene therapy, and clinical trialsACTIVEJun 14, 2020
045Providing patient advocate services in the field of genetic disease, gene therapy, and potential curative therapies; providing personal support services for patients, namely, emotional counseling and emotional support by providing personal emotional support information in the fields of genetic disease, gene therapy, and potential curative therapies; providing patient advocacy and personal emotional support services to potential participants and participants in clinical trials for genetic diseases and gene therapy; providing information in the field of personal emotional support of gene therapy patients and patients' familiesACTIVEJun 14, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jul 7, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jun 17, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 20, 2026EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Apr 19, 2026PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Apr 15, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 15, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Dec 16, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 16, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 21, 2025DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Nov 21, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 1, 2025IUCNNOTICE OF ALLOWANCE CANCELLED—
Oct 1, 2025EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Apr 14, 2025EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 25, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 7, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 7, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 9, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 9, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 9, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 4, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2024ALIEASSIGNED TO LIE—
Aug 8, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 8, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 8, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 8, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 8, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 8, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 8, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 8, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 8, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2024DOCKASSIGNED TO EXAMINER—
Oct 11, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 2, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance